
### [MONDO:0018101](http://purl.obolibrary.org/obo/MONDO_0018101)
**Label:** familial primary hypomagnesemia with normocalciuria and normocalcemia

**Subclasses:** [MONDO:0014631](http://purl.obolibrary.org/obo/MONDO_0014631) (hypomagnesemia, seizures, and mental retardation), [MONDO:0012717](http://purl.obolibrary.org/obo/MONDO_0012717) (renal hypomagnesemia 4), [MONDO:0013480](http://purl.obolibrary.org/obo/MONDO_0013480) (renal hypomagnesemia 6), 

**Mapped go classes:** [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity), [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity), [GO:0015693](http://purl.obolibrary.org/obo/GO_0015693) (magnesium ion transport), [GO:0015095](http://purl.obolibrary.org/obo/GO_0015095) (magnesium ion transmembrane transporter activity), [GO:0008015](http://purl.obolibrary.org/obo/GO_0008015) (blood circulation), [GO:0044332](http://purl.obolibrary.org/obo/GO_0044332) (Wnt signaling pathway involved in dorsal/ventral axis specification), [GO:0043235](http://purl.obolibrary.org/obo/GO_0043235) (receptor complex), [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006811](http://purl.obolibrary.org/obo/GO_0006811) (ion transport), [GO:0043231](http://purl.obolibrary.org/obo/GO_0043231) (intracellular membrane-bounded organelle), [GO:0005509](http://purl.obolibrary.org/obo/GO_0005509) (calcium ion binding), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0060070](http://purl.obolibrary.org/obo/GO_0060070) (canonical Wnt signaling pathway), [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding), [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane), [GO:0010960](http://purl.obolibrary.org/obo/GO_0010960) (magnesium ion homeostasis), [GO:0051216](http://purl.obolibrary.org/obo/GO_0051216) (cartilage development), 

**Class expressions from DL-Learner:**

- [GO:0044332](http://purl.obolibrary.org/obo/GO_0044332) (Wnt signaling pathway involved in dorsal/ventral axis specification) 57.14%
- [GO:0042813](http://purl.obolibrary.org/obo/GO_0042813) (Wnt-activated receptor activity) 57.14%
- [GO:0017147](http://purl.obolibrary.org/obo/GO_0017147) (Wnt-protein binding) 57.14%
- [GO:0016323](http://purl.obolibrary.org/obo/GO_0016323) (basolateral plasma membrane) 57.14%
- [GO:0008083](http://purl.obolibrary.org/obo/GO_0008083) (growth factor activity) 57.14%
- [GO:0007420](http://purl.obolibrary.org/obo/GO_0007420) (brain development) 57.14%
- [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding) 57.14%
- [GO:0032559](http://purl.obolibrary.org/obo/GO_0032559) (adenyl ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 57.14%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 57.14%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 57.14%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 57.14%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032555](http://purl.obolibrary.org/obo/GO_0032555) (purine ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 57.14%
- [GO:0030554](http://purl.obolibrary.org/obo/GO_0030554) (adenyl nucleotide binding) and [GO:0032553](http://purl.obolibrary.org/obo/GO_0032553) (ribonucleotide binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) 57.14%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0097367](http://purl.obolibrary.org/obo/GO_0097367) (carbohydrate derivative binding) 57.14%
- [GO:0008144](http://purl.obolibrary.org/obo/GO_0008144) (drug binding) and [GO:0035639](http://purl.obolibrary.org/obo/GO_0035639) (purine ribonucleoside triphosphate binding) and [GO:0036094](http://purl.obolibrary.org/obo/GO_0036094) (small molecule binding) 57.14%


